Weintraub Bennett

Weintraub Bennett is listed in filings as Director at Apimeds Pharmaceuticals US, Inc. This profile follows SEC Form 4 activity through Nov 13, 2025, including 2 public disclosures. Recent filings connect the profile to Apimeds Pharmaceuticals US, Inc (APUS). The current snapshot covers public activity from Oct 17, 2025 to Nov 13, 2025. Reported amounts are shown as $26.7K to $5.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.